Related Experiment Videos
Laboratory assessment in musculoskeletal disorders
Pieter van Paassen1, Jan Damoiseaux, Jan Willem Cohen Tervaert
1Department of Clinical and Experimental Immunology, University Hospital, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands. p.vanpassen@immuno.unimaas.nl
Best Practice & Research. Clinical Rheumatology
|June 6, 2003
Summary
Autoantibodies are key in diagnosing autoimmune musculoskeletal disorders. Measuring specific autoantibodies aids in diagnosis, prognosis, and monitoring treatment effectiveness for conditions like rheumatoid arthritis and lupus.
Area of Science:
- Immunology
- Rheumatology
- Clinical Diagnostics
Background:
- Autoimmune musculoskeletal disorders involve autoantibodies and autoreactive T cells.
- Autoantibody determination is crucial for diagnosis and has prognostic implications.
- Monitoring autoantibodies can guide treatment response and predict disease relapse.
Purpose of the Study:
- To review the role of autoantibody determination in diagnosing and managing musculoskeletal disorders.
- To discuss clinically relevant autoantibody assays.
- To provide an overview of major autoimmune musculoskeletal conditions.
Main Methods:
- Review of key autoantibody assays: rheumatoid factor (RF), anti-cyclic citrullinated antibody (anti-CCP), antinuclear autoantibodies (ANA), anti-double-stranded DNA, anti-ENA, and ANCA.
- Overview of musculoskeletal disorders including rheumatoid arthritis, lupus, Sjögren's syndrome, systemic sclerosis, polymyositis/dermatomyositis, and vasculitis.
Main Results:
- Specific autoantibodies are essential for diagnosing various autoimmune musculoskeletal conditions.
- Assays for RF, anti-CCP, ANA, anti-dsDNA, anti-ENA, and ANCA are clinically significant.
- These autoantibodies play roles in disease prognosis and monitoring.
Conclusions:
- Autoantibody testing is indispensable for the diagnosis and management of autoimmune musculoskeletal disorders.
- Understanding the characteristics of different autoantibody assays enhances diagnostic accuracy.
- Prognostic and monitoring value of autoantibodies aids in personalized patient care.